TY  - JOUR
AU  - Uras, Iris Z
AU  - Walter, Gina
AU  - Scheicher, Ruth
AU  - Bellutti, Florian
AU  - Prchal-Murphy, Michaela
AU  - Tigan, Anca S
AU  - Valent, Peter
AU  - Heidel, Florian H
AU  - Kubicek, Stefan
AU  - Scholl, Claudia
AU  - Fröhling, Stefan
AU  - Sexl, Veronika
TI  - Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6.
JO  - Blood
VL  - 127
IS  - 23
SN  - 1528-0020
CY  - Stanford, Calif.
PB  - HighWire Press
M1  - DKFZ-2017-05779
SP  - 2890 - 2902
PY  - 2016
AB  - Up to 30
KW  - Mutant Proteins (NLM Chemicals)
KW  - Piperazines (NLM Chemicals)
KW  - Protein Kinase Inhibitors (NLM Chemicals)
KW  - Proto-Oncogene Proteins (NLM Chemicals)
KW  - Pyridines (NLM Chemicals)
KW  - FLT3 protein, human (NLM Chemicals)
KW  - fms-Like Tyrosine Kinase 3 (NLM Chemicals)
KW  - PIM3 protein, human (NLM Chemicals)
KW  - Protein-Serine-Threonine Kinases (NLM Chemicals)
KW  - CDK6 protein, human (NLM Chemicals)
KW  - Cyclin-Dependent Kinase 6 (NLM Chemicals)
KW  - palbociclib (NLM Chemicals)
LB  - PUB:(DE-HGF)16
C6  - pmid:27099147
C2  - pmc:PMC4920675
DO  - DOI:10.1182/blood-2015-11-683581
UR  - https://inrepo02.dkfz.de/record/130701
ER  -